What Role Does Pharmacogenomics Play in Antiarrhythmic Toxicology?
Pharmacogenomics involves studying how genes affect a person's response to drugs. It can play a significant role in antiarrhythmic toxicology by identifying individuals who may be at higher risk for toxicity due to genetic variations. For example, variations in genes affecting drug metabolism enzymes, such as CYP2D6, can influence how drugs like beta-blockers are processed in the body.
